Shared Vision Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$299K Buy
249
+1
+0.4% +$1.02K 0.1% 94
2026
Q1
$228K Hold
248
0.09% 89
2025
Q4
$263K Buy
248
+1
+0.4% +$956 0.11% 86
2025
Q3
$201K Buy
+247
New +$184K 0.09% 98
2025
Q2
Sell
-246
Closed -$204K 86
2025
Q1
$204K Buy
+246
New +$205K 0.11% 78
2024
Q4
Sell
-246
Closed -$218K 77
2024
Q3
$218K Buy
246
+1
+0.4% +$899 0.12% 71
2024
Q2
$222K Buy
+245
New +$196K 0.13% 72

Other funds holding LLY

Shared Vision Wealth Group's LLY Position: Q2 2026 in Review

Shared Vision Wealth Group increased its Eli Lilly (LLY) stake by 0.4% in Q2 2026, buying an estimated $1.02K and bringing the position to 249 shares worth $299K. The position accounts for 0.1% of the portfolio, ranked #94.

Shared Vision Wealth Group first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Shared Vision Wealth Group held 249 shares of Eli Lilly worth $299K as of Q2 2026.
  • Shared Vision Wealth Group bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.1% of Shared Vision Wealth Group's portfolio in Q2 2026, its #94 holding.
  • Shared Vision Wealth Group first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Shared Vision Wealth Group's 13F filing for Q2 2026, filed 31 Jul 2026.